COVID-19 -- South Africa
South Africa recently received 1 million doses of AstraZeneca-Oxford COVID-19 vaccine and was poised to start vaccinating healthcare workers, but yesterday [7 Feb 2021], health officials announced a pause for the rollout to investigate early findings that it offered little protection against mild-to-moderate disease caused by variant 501Y.V2, lineage B.1.351 that's dominant in the country.
New questions about the vaccine come as World Health Organization (WHO) advisers this week consider it
Read more about it at HealthMap Global Disease Alerts via http://healthmap.org/ln.php?8178387&promed&0
No comments:
Post a Comment